Achieve Life Sciences (ACHV) Operating Leases (2018 - 2025)
Achieve Life Sciences (ACHV) recorded quarterly Operating Leases of $5000.0 in Q4 2025, down 76.19% on a QoQ basis from $21000.0 in Q3 2025, and down 92.42% year-over-year from $66000.0 in Q4 2024.
Achieve Life Sciences (ACHV) Operating Leases (2018 - 2025) Analysis & Trends
Achieve Life Sciences has disclosed Operating Leases across 8 years of filings, most recently posting $5000.0 for Q4 2025.
- Quarterly Operating Leases fell 92.42% year-over-year to $5000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5000.0 (down 92.42% YoY) and the FY2025 annual result came in at $5000.0, down 92.42% from the prior year.
- Operating Leases retreated to $5000.0 in Q4 2025, from $21000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $69000.0 in Q4 2022 and troughed at $4000.0 in Q4 2021.
- A 5-year average of $35500.0 and a median of $37500.0 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases slumped 94.81% — and 2022, when it soared 1625.0%.
- Tracing ACHV's Operating Leases over 5 years: stood at $4000.0 in 2021, then surged by 1625.0% to $69000.0 in 2022, then plunged by 91.3% to $6000.0 in 2023, then soared by 1000.0% to $66000.0 in 2024, then tumbled by 92.42% to $5000.0 in 2025.
- Business Quant data shows ACHV's Operating Leases at $5000.0 in Q4 2025, $21000.0 in Q3 2025, and $37000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 54,000.00 |
| Dec 31, 2022 | 69,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 77,000.00 |
| Sep 30, 2020 | 94,000.00 |
| Jun 30, 2020 | 110,000.00 |
| Mar 31, 2020 | 118,000.00 |
| Dec 31, 2019 | 159,000.00 |
| Sep 30, 2019 | 212,000.00 |